Breast cancer patients who take the drug tamoxifen for five or more years may be at increased risk of developing a rare but aggressive breast cancer in their opposite breast, but tamoxifen use shouldn’t change, researchers report.
View original here:
Tamoxifen: Risk of Rare Second Breast Cancer?
The aromatase inhibitor Femara may equal the drug tamoxifen for women with estrogen-sensitive breast cancer, a new study shows.
Read the rest here:
Femara vs. Tamoxifen for Breast Cancer
Depression may dim activity in brain regions tied to reward and pleasure, Canadian researchers report.
See original here:
Depression Dulls Brain’s Pleasure Sites